ARDS
Closed
Aridis Pharmaceuticals Inc
0.0001
0.0000 (0.00%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 0.0001
Day's Range: 0.0001 - 0.0001
Send
sign up or login to leave a comment!
When Written:
0.3141
Aridis Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections. The company's proprietary technology platform, MabIgX, enables the rapid discovery of monoclonal antibodies against a wide range of infectious agents, including those that are resistant to current treatments. Aridis Pharmaceuticals also has a pipeline of product candidates in various stages of development, including AR-301, a monoclonal antibody targeting Pseudomonas aeruginosa, and AR-105, a monoclonal antibody targeting Acinetobacter baumannii. The company is headquartered in San Jose, California and was founded in 2003.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








